Cutting edge: Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 6959-6962

  Dunbar, P Rod ^a   Chen, Ji Li ^a   Chao, David ^b   Rust, Nigel ^b   Teisserenc, Helene ^a   Ogg, Graham S ^a   Romero, Pedro ^d   Weynants, Patrick ^c   Cerundolo, Vincenzo ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL SELECTION; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; LYMPHOCYTE CLONE; MALE; MELANOMA; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, NEOPLASM; CLONE CELLS; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; OLIGOPEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0033564637     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Van den Eynde, B. J., and P. van der Bruggen. 1997. T cell defined tumor antigens. Curr. Opin. Immunol. 9:684.
2. Boon, T., and L. J. Old. 1997. Cancer tumor antigens. Curr. Opin. Immunol. 9:681.
3. Yee, C., S. R. Riddell, and P. D. Greenberg. 1997. Prospects for adoptive T cell therapy. Curr. Opin. Immunol. 9:702.
4. Romero P., P. R. Dunbar, D. Valmori, M. Pittet, G. S. Ogg, D. Rimoldi, J.-L. Chen, D. Lienard, J.-C. Cerottini, and V. Cerundolo. 1998. Ex-vivo staining of metallic lymph nodes by class I MHC tetramers reveals high numbers of antigen-experienced tumor-specific cytotoxic T lymphocytes. J. Exp. Med. 188: 1641.
5. Dunbar, P. R., G. S. Ogg, J. Chen, N. Rust, P. Van der Bruggen, and V. Cerundolo. 1998. Direct isolation, phenotyoing, and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr. Biol. 8:413.
6. Altman J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
7. Ogg, G. S., P. R. Dunbar, P. Romero, J.-L. Chen, and V. Cerundolo. 1998. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med. 188:1203.
8. + T cell clones correlates with their levels of expression of adhesion molecules. J. Exp. Med. 175:895.
9. Rice, G. E., and M. P. Bevilacqua. 1989. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246:1303.
10. Rice, G. E., J. M. Munro, and M. P. Bevilacqua. 1990. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes: a CD11/ CD18-independent adhesion mechanism. J. Exp. Med. 171:1369.
11. Picker, L. J., T. K. Kishimoto, C. W. Smith, R. A. Warnock, and E. C. Butcher. 1991. ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 349:796.
12. + T cells usable in immunotherapy. Nat. Biotechnol. 16:281.